Ricin and saporin: Plant enzymes for the research and the clinics

Current Chemical Biology

Volumn 4, Issue 2, 2010, Pages 99-107

  Giansanti, Francesco ^a   Di Leandro, Luana ^a   Koutris, Ilias ^a   Cialfi, Alessio ^a   Benedetti, Elisabetta ^a   Laurenti, Giulio ^a   Pitari, Giuseppina ^a   Ippoliti, Rodolfo ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Immunotoxins; N glycosidases; Ricin; Saporin; Toxins

Indexed keywords

CYTOTOXIC AGENT; ELONGATION FACTOR 2; IMMUNOTOXIN; RECOMBINANT PROTEIN; RIBOSOME INACTIVATING PROTEIN; RIBOSOME RNA; RICIN; SAPORIN;

CYTOLOGY; ENZYME ACTIVITY; EUKARYOTE; HUMAN; LEUKEMIA; NONHUMAN; PRIORITY JOURNAL; PROKARYOTE; PROTEIN EXPRESSION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REVIEW; SUICIDE GENE THERAPY;

EUKARYOTA; PROKARYOTA;

EID: 77951612566     PISSN: 18723136     EISSN: None     Source Type: Journal    
DOI: 10.2174/187231310791170801     Document Type: Review

References (179)

1. Stirpe F, Barbieri L. Ribosome-inactivating proteins up to date. FEBS Lett 1986; 195: 1-8.
2. Endo Y, Tsurugi K, Lambert JM. The site of action of six different ribosome-inactivating proteins from plants on eukaryotic ribosomes: the RNA N-glycosidase activity of the proteins. Biochem Biophys Res Commun 1988; 150: 1032-1036
3. Saxena SK, O'Brien AD, Ackerman EJ. Shiga toxin, Shiga-like toxin II variant, and ricin are all single-site RNA N-glycosidases of 28 S RNA when microinjected into Xenopus oocytes. J Biol Chem 1989; 264: 596-601.
4. Stirpe F, Barbieri L, Battelli MG, Soria M, Lappi DA. Ribosome-inactivating proteins from plants: present status and future prospects. Biotechnology (NY) 1992; 10: 405-412
5. Falnes PO, Sandvig K. Penetration of protein toxins into cells. Curr Opin Cell Biol 2000; 12: 407-413
6. Fabbrini MS, Flavell DJ, Ippoliti R. in "Bacterial, Plant and Animal toxins". Research Signpost eds. (Trivandrum-695 023, India) 2003; 69-99.
7. Sandvig K. Shiga toxins. Toxicon 2001; 39:1629-1635
8. Olsnes S, Fernandez-Puentes C, Carrasco L, Vazquez D. Ribosome inactivation by the toxic lectins abrin and ricin. Kinetics of the enzymic activity of the toxin A-chains. Eur J Biochem 1975; 60: 281-288
9. Eiklid K, Olsnes S, Pihl A. Entry of lethal doses of abrin, ricin and modeccin into the cytosol of HeLa cells. Exp Cell Res 1980; 126: 321-326 (Pubitemid 10041165)
10. Komatsu N, Oda T, Muramatsu T. Involvement of both caspase-like proteases and serine proteases in apoptotic cell death induced by ricin, modeccin, diphtheria toxin, and pseudomonas toxin. J Biochem 1998; 124: 1038-1044 (Pubitemid 28544918)
11. Gan YH, Peng SQ, Liu HY. Molecular mechanism of apoptosis induced by ricin in HeLa cells. Acta Pharmacol Sin 2000; 21: 243-248
12. Tamura T, Sadakata N, Oda T, Muramatsu T. Role of zinc ions in ricin-induced apoptosis in U937 cells. Toxicol Lett 2002; 132: 141-151
13. Tamura T, Tsuruta N, Hirano K, Yamaguchi K, Oda T. Butyric acid sensitizes Vero cells to ricin-induced apoptosis via accelerated activation of multiple signal transduction pathways. Cell Struct Funct 2003; 28: 475-485 (Pubitemid 38256615)
14. Wu YH, Shih SF, Lin JY. Ricin Triggers Apoptotic Morphological Changes through Caspase-3 Cleavage of BAT3. J Biol Chem 2004; 279: 19264-19275
15. Li J, Xia X, Ke Y, Nie H, Smith MA, Zhu X. Trichosanthin induced apoptosis in HL-60 cells via mitochondrial and endoplasmic reticulum stress signaling pathways. Biochim Biophys Acta 2007; 1770: 1169-1180 (Pubitemid 47009016)
16. Fujii J, Wood K, Matsuda F, et al. Shiga toxin 2 causes apoptosis in human brain microvascular endothelial cells via C/EBP homologous protein. Infect Immun 2008; 76: 3679-3689
17. Polito L, Bortolotti M, Farini V, Battelli MG, Barbieri L, Bolognesi A. Saporin induces multiple death pathways in lymphoma cells with different intensity and timing as compared to ricin. Int J Biochem Cell Biol 2009; 41: 1055-1061
18. Patocka J, Streda L. Protein biotoxins of military significance. Acta Medica (Hradec Kralove) 2006; 49: 3-11.
19. Papaloucas M, Papaloucas C, Stergioulas A. Ricin and the assassination of Georgi Markov. Pak J Biol Sci 2008; 11: 2370-2371
20. Madsen JM. Toxins as weapons of mass destruction. A comparison and contrast with biological-warfare and chemical-warfare agents. Clin Lab Med 2001; 21: 593-605.
21. Knight B. Ricin-a potent homicidal poison. Br Med J 1979; 1: 350-351
22. Crompton R, Gall D. Georgi Markov-death in a pellet. Med Leg J 1980; 48: 51-62.
23. Kreitman RJ. Toxin-labeled monoclonal antibodies. Curr Pharm Biotechnol 2001; 2: 313-325
24. Frankel AE, Neville DM, Bugge TA, Kreitman RJ, Leppla SH. Immunotoxin therapy of hematologic malignancies. Semin Oncol 2003; 30: 545-557
25. Kreitman RJ, Pastan I. Immunotoxins in the treatment of hematologic malignancies. Curr Drug Targets 2006; 7: 1301-1311
26. Pastan I, Hassan R, FitzGerald DJ, Kreitman RJ. Immunotoxin treatment of cancer. Annu Rev Med 2007; 58: 221-237
27. Endo Y, Tsurugi K. RNA N-glycosidase activity of ricin A-chain. Mechanism of action of the toxic lectin ricin on eukaryotic ribosomes. J Biol Chem 1987; 262: 8128-8130 (Pubitemid 17104265)
28. Endo Y, Mitsui K, Motizuki M, Tsurugi K. The mechanism of action of ricin and related toxic lectins on eukaryotic ribosomes. The site and the characteristics of the modification in 28 S ribosomal RNA caused by the toxins. J Biol Chem 1987; 262: 5908-5912
29. Endo Y, Tsurugi K, Yutsudo T, Takeda Y, Ogasawara T, Igarashi K. Site of action of a Vero toxin (VT2) from Escherichia coli O157: H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. Eur J Biochem 1988; 171: 45-50.
30. Chaddock JA, Lord JM, Hartley MR, Roberts LM. Pokeweed antiviral protein (PAP) mutations which permit E.coli growth do not eliminate catalytic activity towards prokaryotic ribosomes. Nucleic Acids Res 1994; 22: 1536-1540
31. Chaddock JA, Monzingo AF, Robertus JD, Lord JM, Roberts LM. Major structural differences between pokeweed antiviral protein and ricin A-chain do not account for their differing ribosome specificity. Eur J Biochem 1996; 235: 159-166
32. Ippoliti R, Lendaro E, Bellelli A, Brunori M. A ribosomal protein is specifically recognized by saporin, a plant toxin which inhibits protein synthesis. FEBS Lett 1992; 298: 145-148
33. Vater CA, Bartle LM, Leszyk JD, Lambert JM, Goldmacher VS. Ricin A chain can be chemically cross-linked to the mammalian ribosomal proteins L9 and L10e. J Biol Chem 1995; 270: 12933-12940
34. Hudak KA, Dinman JD, Tumer NE. Pokeweed antiviral protein accesses ribosomes by binding to L3. J Biol Chem 1999; 274: 3859-3864 (Pubitemid 29077236)
35. Chan DS, Chu LO, Lee KM, et al. Interaction between trichosanthin, a ribosome-inactivating protein, and the ribosomal stalk protein P2 by chemical shift perturbation and mutagenesis analyses. Nucleic Acids Res 2007; 35: 1660-1672
36. Chiou JC, Li XP, Remacha M, Ballesta JP, Tumer NE. The ribosomal stalk is required for ribosome binding, depurination of the rRNA and cytotoxicity of ricin A chain in Saccharomyces cerevisiae. Mol Microbiol 2008; 70: 1441-1452
37. Too PH, Ma MK, Mak AN, et al. The C-terminal fragment of the ribosomal P protein complexed to trichosanthin reveals the interaction between the ribosome-inactivating protein and the ribosome. Nucleic Acids Res 2009; 37: 602-610
38. Honjo E, Watanabe K, Tsukamoto T. Real-time kinetic analyses of the interaction of ricin toxin A-chain with ribosomes prove a conformational change involved in complex formation. J Biochem 2002; 131: 267-275 (Pubitemid 34194364)
39. Rutenber E, Robertus JD. Structure of ricin B-chain at 2.5 Å resolution. Proteins 1991; 10: 260-269
40. Monzingo AF, Collins EJ, Ernst SR, Irvin JD, Robertus JD. The 2.5 Å structure of pokeweed antiviral protein. J Mol Biol 1993; 233: 705-715
41. Gao B, Ma XQ, Wang YP, Chen SZ, Wu S, Dong YC. Refined structure of trichosanthin at 1.73 Å resolution. Sci China B 1994; 37: 59-73.
42. Ren J, Wang Y, Dong Y, Stuart DI. The N-glycosidase mechanism of ribosome-inactivating proteins implied by crystal structures of alpha-momorcharin. Structure 1994; 2: 7-16. (Pubitemid 2036417)
43. Tahirov TH, Lu TH, Liaw YC, Chen YL, Lin JY. Crystal structure of abrin-a at 2.14 Å. J Mol Biol 1995; 250: 354-367.
44. Erratum in: J Mol Biol 1995; 252: 154-167
45. Hosur MV, Nair B, Satyamurthy P, Misquith S, Surolia A, Kannan KK. X-ray structure of gelonin at 1.8 Å resolution. J Mol Biol 1995; 250: 368-380
46. Savino C, Federici L, Ippoliti R, Lendaro E, Tsernoglou D. The crystal structure of saporin SO6 from Saponaria officinalis and its interaction with the ribosome. FEBS Lett 2000; 470: 239-243 (Pubitemid 30169271)
47. Robertus JD, Monzingo AF. The structure of ribosome inactivating proteins. Mini Rev Med Chem 2004; 4: 477-486
48. Kurinov IV, Rajamohan F, Uckun FM. High resolution X-ray structure and potent anti-HIV activity of recombinant dianthin antiviral protein. Arzneimittelforschung 2004; 54: 692-702. (Pubitemid 39422848)
49. Fermani S, Falini G, Ripamonti A, Polito L, Stirpe F, Bolognesi A. The 1.4 angstroms structure of dianthin 30 indicates a role of surface potential at the active site of type 1 ribosome inactivating proteins. J Struct Biol 2005; 149: 204-212 (Pubitemid 40170102)
50. Mishra V, Bilgrami S, Sharma RS, et al. Crystal structure of himalayan mistletoe ribosome-inactivating protein reveals the presence of a natural inhibitor and a new functionally active sugar-binding site. J Biol Chem 2005; 280: 20712-20721 (Pubitemid 40776776)
51. Hou X, Chen M, Chen L, Meehan EJ, Xie J, Huang M. X-ray sequence and crystal structure of luffaculin 1, a novel type 1 ribosome-inactivating protein. BMC Struct Biol 2007; 7: 29-39.
52. Ruggiero A, Chambery A, Di Maro A, Parente A, Berisio R. Atomic resolution (1.1 Å) structure of the ribosome-inactivating protein PD-L4 from Phytolacca dioica L. leaves. Proteins 2008; 71: 8-15.
53. Nagasawa Y, Fujii K, Yoshikawa T, Kobayashi Y, Kondo T. Pokeweed antiviral protein region Gly209-Lys225 is critical for RNA N-glycosidase activity of the prokaryotic ribosome. Phytochemistry 2008; 69: 1653-1660
54. Hou X, Meehan EJ, Xie J, Huang M, Chen M, Chen L. Atomic resolution structure of cucurmosin, a novel type 1 ribosome-inactivating protein from the sarcocarp of Cucurbita moschata. J Struct Biol 2008; 164: 81-87
55. Azzi A, Wang T, Zhu DW, Zou YS, Liu WY, Lin SX. Crystal structure of native cinnamomin isoform III and its comparison with other ribosome inactivating proteins. Proteins 2009; 74: 250-255
56. Hudak KA, Wang P, Tumer NE. A novel mechanism for inhibition of translation by pokeweed antiviral protein: depurination of the capped RNA template. RNA 2000; 6: 369-380 (Pubitemid 30161281)
57. Barbieri L, Valbonesi P, Govoni M, Pession A, Stirpe F. Polynucleotide:adenosine glycosidase activity of saporin-L1: effect on various forms of mammalian DNA. Biochim Biophys Acta 2000; 1480: 258-266 (Pubitemid 30427403)
58. Peumans WJ, Hao Q, Van Damme EJ. Ribosome-inactivating proteins from plants: more than RNA N-glycosidases? FASEB J 2001; 15: 1493-1506
59. Brigotti M, Alfieri R, Sestili P, et al. Damage to nuclear DNA induced by Shiga toxin 1 and ricin in human endothelial cells. FASEB J 2002; 16: 365-372 (Pubitemid 34195297)
60. Bagga S, Seth D, Batra JK. The cytotoxic activity of ribosomeinactivating protein saporin-6 is attributed to its rRNA N-glycosidase and internucleosomal DNA fragmentation activities. J Biol Chem 2003; 278: 4813-4820 (Pubitemid 36800985)
61. Barbieri L, Brigotti M, Perocco P, et al. Ribosome-inactivating proteins depurinate poly(ADP-ribosyl)ated poly(ADP-ribose) polymerase and have transforming activity for 3T3 fibroblasts. FEBS Lett 2003; 538: 178-182 (Pubitemid 36287447)
62. Park SW, Vepachedu R, Owens RA, Vivanco JM. The N-glycosidase activity of the ribosome-inactivating protein ME1 targets single-stranded regions of nucleic acids independent of sequence or structural motifs. J Biol Chem 2004; 279: 34165-34174 (Pubitemid 39318039)
63. Gasperi-Campani A, Brognara I, Baiocchi D, Roncuzzi L. Mitochondrial DNA D-loop as a new target of Saporin 6 nuclease activity. Toxicon 2005; 45: 475-480 (Pubitemid 40269937)
64. Gandhi R, Manzoor M, Hudak KA. Depurination of Brome mosaic virus RNA3 in vivo results in translation-dependent accelerated degradation of the viral RNA. J Biol Chem 2008; 283: 32218-32228
65. Agapov II, Tonevitsky AG, Moysenovich MM, Maluchenko NV, Weyhenmeyer R, Kirpichnikov MP. Mistletoe lectin dissociates into catalytic and binding subunits before translocation across the membrane to the cytoplasm. FEBS Lett 1999; 452: 211-214 (Pubitemid 29301746)
66. Bellisola G, Fracasso G, Ippoliti R, et al. Reductive activation of ricin and ricin A-chain immunotoxins by protein disulfide isomerase and thioredoxin reductase. Biochem Pharmacol 2004; 67: 1721-1731 (Pubitemid 38479850)
67. Mohanraj D, Ramakrishnan S. Cytotoxic effects of ricin without an interchain disulfide bond: genetic modification and chemical cross-linking studies. Biochim Biophys Acta 1995; 1243: 399-406.
68. Nielsen K, Boston RS. Ribosome-inactivating proteins : A plant perspective. Annu Rev Plant Physiol Plant Mol Biol 2001; 52: 785-816.
69. Lord JM, Roberts LM, Robertus JD. Ricin: structure, mode of action, and some current applications FASEB J 1994; 8: 201-208
70. Olsnes S, Kozlov JV. Ricin. Toxicon 2001; 39: 1723-1728
71. Hartley MR, Lord JM. Cytotoxic ribosome-inactivating lectins from plants. Biochim Biophys Acta 2004; 1701: 1-14.
72. Olsnes S. The history of ricin, abrin and related toxins. Toxicon 2004; 44: 361-370 (Pubitemid 39070638)
73. Audi J, Belson M, Patel M, Schier J, Osterloh J. Ricin poisoning: a comprehensive review. JAMA 2005; 294: 2342-2351
74. Weston SA, Tucker AD, Thatcher DR, Derbyshire DJ, Pauptit RA. X-ray structure of recombinant ricin A-chain at 1.8 Å resolution. J Mol Biol 1994; 244: 410-422 (Pubitemid 24378166)
75. Katzin BJ, Collins EJ, Robertus JD. Structure of ricin A-chain at 2.5 Å. Proteins 1991; 10: 251-259
76. Mlsna D, Monzingo AF, Katzin BJ, Ernst S, Robertus JD. Structure of recombinant ricin A chain at 2.3 Å. Protein Sci 1993; 2: 429-435 (Pubitemid 23071291)
77. Chen XY, Link TM, Schramm VL. Ricin A-chain: kinetics, mechanism, and RNA stem-loop inhibitors. Biochemistry 1998; 37: 11605-11613
78. Tanaka KS, Chen XY, Ichikawa Y, Tyler PC, Furneaux RH, Schramm VL. Ricin A-chain inhibitors resembling the oxacarbenium ion transition state. Biochemistry 2001; 40: 6845-6851 (Pubitemid 32538230)
79. Roday S, Amukele T, Evans GB, Tyler PC, Furneaux RH, Schramm VL. Inhibition of ricin A-chain with pyrrolidine mimics of the oxacarbenium ion transition state. Biochemistry 2004; 43: 4923-4933 (Pubitemid 38544446)
80. Marsden CJ, Fülöp V, Day PJ, Lord JM. The effect of mutations surrounding and within the active site on the catalytic activity of ricin A chain. Eur J Biochem 2004; 271: 153-162 (Pubitemid 38122174)
81. Villafranca JE, Robertus JD. Ricin B chain is a product of gene duplication. J Biol Chem 1981; 256: 554-556
82. Henley JR, Krueger EW, Oswald BJ, McNiven MA. Dynamin-mediated internalization of caveolae. J Cell Biol 1998; 141: 85-99.
83. Llorente A, van Deurs B, Sandvig K. Transport of apically but not basolaterally internalized ricin to the Golgi apparatus is stimulated by 8-Br-cAMP in MDCK cells. FEBS Lett 1998; 431: 200-204 (Pubitemid 28334216)
84. Simpson JC, Smith DC, Roberts LM, Lord JM. Expression of mutant dynamin rotects cells against diphtheria toxin but not against ricin. Exp Cell Res 1998; 239: 293-300.
85. Rodal SK, Skretting G, Garred Ø, Vilhardt F, van Deurs B, Sandvig, K. Extraction of cholesterol with methyl-betacyclodextrin perturbs formation of clathrin-coated endocytic vesicles Mol Biol Cell 1999; 10: 961-974
86. Sandvig K, Spilsberg B, Lauvrak SU, Torgersen ML, Iversen TG, van Deurs B. Pathways followed by protein toxins into cells. Int J Med Microbiol 2004; 293: 483-490 (Pubitemid 38667570)
87. Grimmer S, Spilsberg B, Hanada K, Sandvig K. Depletion of sphingolipids facilitates endosome to Golgi transport of ricin. Traffic 2006; 7: 1243-1253 (Pubitemid 44207838)
88. Newton DL, Wales R, Richardson PT, et al. Cell surface and intracellular functions for ricin galactose binding. J Biol Chem 1992; 267: 11917-11922
89. Lendaro E, Ippoliti R, Bellelli A, et al. Intracellular dynamics of ricin followed by fluorescence microscopy on living cells reveals a rapid accumulation of the dimeric toxin in the Golgi apparatus. FEBS Lett 1994; 344: 99-104.
90. van Deurs B, Sandvig K, Petersen OW, Olsnes S, Simons K, Griffiths G. Estimation of the amount of internalized ricin that reaches the trans-Golgi network. J Cell Biol 1988; 106: 253-267 (Pubitemid 18052176)
91. Lord JM, Roberts LM. Toxin entry: retrograde transport through the secretory pathway. J Cell Biol 1998; 140: 733-736 (Pubitemid 28141213)
92. Roberts L. M., Smith D. C. Ricin: the endoplasmic reticulum connection Toxicon 2004; 44: 469-472
93. Rapak A, Falnes PO, Olsnes S. Retrograde transport of mutant ricin to the endoplasmic reticulum with subsequent translocation to cytosol. Proc Natl Acad Sci USA 1997; 94: 3783-3788 (Pubitemid 27180450)
94. Pelham HR. Recycling of proteins between the endoplasmic reticulum and Golgi complex. Curr Opin Cell Biol 1991; 3: 585-591 (Pubitemid 121006115)
95. Pelham HR. The dynamic organisation of the secretory pathway. Cell Struct Funct 1996; 21: 413-419
96. Wales R, Chaddock JA, Roberts LM, Lord JM. Addition of an ER retention signal to the ricin A chain increases the cytotoxicity of the holotoxin. Exp Cell Res 1992; 203: 1-4.
97. Wales R, Roberts LM, Lord JM. Addition of an endoplasmic reticulum retrieval sequence to ricin A chain significantly increases its cytotoxicity to mammalian cells. J Biol Chem 1993; 268: 23986-23990 (Pubitemid 23335376)
98. Day PJ, Owens SR, Wesche J, Olsnes S, Roberts LM, Lord JM. An interaction between ricin and calreticulin that may have implications for toxin trafficking. J Biol Chem 2001; 276: 7202-7208 (Pubitemid 37392023)
99. Wesche J, Rapak A, Olsnes S. Dependence of ricin toxicity on translocation of the toxin A-chain from the endoplasmic reticulum to the cytosol. J Biol Chem 1999; 274: 34443-34449
100. Spooner RA, Hart PJ, Cook JP, et al. Cytosolic chaperones influence the fate of a toxin dislocated from the endoplasmic reticulum. Proc Natl Acad Sci USA 2008; 105: 17408-17413
101. Argent RH, Parrott AM, Day PJ, et al. Ribosome-mediated folding of partially unfolded ricin A-chain. J Biol Chem 2000; 275: 9263-9269
102. Deeks ED, Cook JP, Day PJ, Smith DC, Roberts LM, Lord JM. The low lysine content of ricin A chain reduces the risk of proteolytic degradation after translocation from the endoplasmic reticulum to the cytosol. Biochemistry 2002; 41: 3405-3413
103. Maras B, Ippoliti R, De Luca E, et al. The amino acid sequence of a ribosome-inactivating protein from Saponaria officinalis seeds. Biochem Int 1990; 21: 831-838
104. Cenini P, Bolognesi A, Stirpe F. Ribosome-inactivating proteins from plants inhibit ribosome activity of Trypanosoma and Leishmania. J Protozool 1988; 35: 384-387
105. Ferrari C, Barbieri L, Stirpe F. Effects of plant ribosomein-activating proteins on ribosomes from Musca domestica. Comp Biochem Physiol B 1991; 100: 223-227
106. Battelli MG, Montacuti V, Stirpe F. High sensitivity of cultured human trophoblasts to ribosome-inactivating proteins. Exp Cell Res 1992; 201: 109-112
107. Barbieri L, Ferreras JM, Barraco A, Ricci P, Stirpe F. Some ribosome-inactivating proteins depurinate ribosomal RNA at multiple sites. Biochem J 1992; 286: 1-4.
108. Cavallaro U, Nykjaer A, Nielsen M, Soria MR. Alpha 2-macroglobulin receptor mediates binding and cytotoxicity of plant ribosome-inactivating proteins. Eur J Biochem 1995; 232: 165-171
109. Fabbrini MS, Rappocciolo E, Carpani D, et al. Characterization of a saporin isoform with lower ribosome-inhibiting activity. Biochem J 1997; 322: 719-727 (Pubitemid 27135616)
110. Flavell DJ. Saporin immunotoxins. Curr Top Microbiol Immunol 1998; 234: 57-61.
111. Lappi DA, Martineau D, Baird A. Biological and chemical characterization of basic FGF-saporin mitotoxin. Biochem Biophys Res Commun 1989; 160: 917-923 (Pubitemid 19140606)
112. Beitz JG, Davol P, Clark JW, et al. Antitumor activity of basic fibroblast growth factor-saporin mitotoxin in vitro and in vivo. Cancer Res 1992; 52: 227-230
113. Lappi DA, Martineau D, Maher PA, et al. Basic fibroblast growth factor in cells derived from Dupuytren's contracture: synthesis, presence, and implications for treatment of the disease. J Hand Surg Am 1992; 17: 324-332
114. Lappi DA, Matsunami R, Martineau D, Baird A. Reducing the heterogeneity of chemically conjugated targeted toxins: homogeneous basic FGF-saporin. Anal Biochem 1993; 212: 446-451 (Pubitemid 23245096)
115. Lappi DA, Ying W, Barthelemy I, et al. Expression and activities of a recombinant basic fibroblast growth factor-saporin fusion protein. J Biol Chem 1994; 269: 12552-12558 (Pubitemid 24982277)
116. Buechler YJ, Sosnowski BA, Victor KD, et al. Synthesis and characterization of a homogeneous chemical conjugate between basic fibroblast growth factor and saporin. Eur J Biochem 1995; 234: 706-713
117. Ippoliti R, Lendaro E, D'Agostino I, et al. A chimeric saporintransferrin conjugate compared to ricin toxin: role of the carrier in intracellular transport and toxicity. FASEB J 1995; 9: 1220-1225
118. Davol P, Frackelton AR Jr. The mitotoxin, basic fibroblast growth factor-saporin, effectively targets human prostatic carcinoma in an animal model. J Urol 1996; 156: 1174-1179 (Pubitemid 26269851)
119. Wee WR, Parandoosh Z, Sakamoto T, Caton M, Nova M, McDonnell PJ. Antiproliferative effect of basic fibroblast growth factorsaporin mitotoxin on keratocytes in culture. Korean J Ophthalmol 1996; 10: 1-7.
120. Fabbrini MS, Carpani D, Bello-Rivero I, Soria MR. The amino-terminal fragment of human urokinase directs a recombinant chimeric toxin to target cells: internalization is toxin mediated. FASEB J 1997; 11: 1169-1176 (Pubitemid 27481441)
121. Chandler LA, Sosnowski BA, McDonald JR, et al. Targeting tumor cells via EGF receptors: selective toxicity of an HBEGF-toxin fusion protein. Int J Cancer 1998; 78: 106-111
122. Ippoliti R, Lendaro E, Benedetti PA, et al. Endocytosis of a chimera between human pro-urokinase and the plant toxin saporin: an unusual internalization mechanism. FASEB J 2000; 14: 1335-1344 (Pubitemid 30439742)
123. Cavallaro U, del Vecchio A, Lappi DA, Soria MR. A conjugate between human urokinase and saporin, a type-1 ribosomein-activating protein, is selectively cytotoxic to urokinase receptorexpressing cells. J Biol Chem 1993; 268: 23186-23190 (Pubitemid 23328032)
124. Baggaa S, Hosurb MV, Batraa JK. Cytotoxicity of ribosomeinactivating protein saporin is not mediated through α2-macroglobulin receptor. FEBS Lett 2003; 541: 16-20.
125. Weyergang A, Selbo PK, Berg K. Photochemically stimulated drug delivery increases the cytotoxicity and specificity of EGF-saporin. J Control Release 2006; 111: 165-173 (Pubitemid 43290005)
126. Yip WL, Weyergang A, Berg K, Tønnesen HH, Selbo PK. Targeted delivery and enhanced cytotoxicity of cetuximab-saporin by photochemical internalization in EGFR-positive cancer cells. Mol Pharm 2007; 4: 241-251 (Pubitemid 46640600)
127. Lai PS, Pai CL, Peng CL, Shieh MJ, Berg K, Lou PJ. Enhanced cytotoxicity of saporin by polyamidoamine dendrimer conjugation and photochemical internalization. J Biomed Mater Res A 2008; 87: 147-155
128. Ippoliti R, Ginobbi P, Lendaro E, et al. The effect of monensin and chloroquine on the endocytosis and toxicity of chimeric toxins. Cell Mol Life Sci 1998; 54: 866-875 (Pubitemid 28425317)
129. Geden SE, Gardner RA, Fabbrini MS, Ohashi M, Phanstiel Iv O, Teter K. Lipopolyamine treatment increases the efficacy of intoxication with saporin and an anticancer saporin conjugate. FEBS J 2007; 274: 4825-4836 (Pubitemid 47353132)
130. Weng A, Bachran C, Fuchs H, Krause E, Stephanowitz H, Melzig MF. Enhancement of saporin cytotoxicity by Gypsophila saponins-More than stimulation of endocytosis. Chem Biol Interact 2009; doi:10.1016/j.cbi.2009.07.007
131. Vago R, Marsden CJ, Lord JM, et al. Saporin and ricin A chain follow different intracellular routes to enter the cytosol of intoxicated cells. FEBS J 2005; 272: 4983-4995 (Pubitemid 41415121)
132. Vallera DA, Myers DE. Immunotoxins containing ricin. Cancer Treat Res 1988; 37: 141-159
133. Vitetta ES, Thorpe PE. Immunotoxins containing ricin or its A chain. Semin Cell Biol 1991; 2: 47-58.
134. Mathew M, Verma R S. Humanized immunotoxins: A new generation of immunotoxins for targeted cancer therapy. Cancer Sci 2009; 100: 1359-1365
135. Lambert JM, Blättler WA, McIntyre GD, Goldmacher VS, Scott CF Jr. Immunotoxins containing single-chain ribosome-inactivating proteins. Cancer Treat Res 1988; 3: 175-209.
136. Kreitman RJ. Immunotoxins for Targeted Cancer Therapy. AAPS J 2006; 8: 532-551
137. Hartley MR, Legname G, Osborn R, Chen Z, Lord JM. Single-chain ribosome inactivating proteins from plants depurinate Escherichia coli 23S ribosomal RNA. FEBS Lett 1991; 290: 65-68
138. O'Hare M, Roberts LM, Thorpe PE, Watson GJ, Prior B, Lord JM. Expression of ricin A chain in Escherichia coli. FEBS Lett 1987; 216: 73-78
139. Legname G, Fossati G, Monzini N, et al. Heterologous expression, purification, activity and conformational studies of different forms of dianthin 30. Biomed Pept Proteins Nucleic Acids 1995; 1: 61-68
140. Fabbrini MS, Carpani D, Soria MR, Ceriotti A. Cytosolic immunization allows the expression of preATF-saporin chimeric toxin in eukaryotic cells. FASEB J 2000; 14: 391-398 (Pubitemid 30086076)
141. Anderson G P, Liu J L, Hale ML, et al. Development of antiricin single domain antibodies toward detection and therapeutic reagents. Anal Chem 2008; 80: 9604-9611
142. Lombardi A, Bursomanno S, Lopardo T, et al. Pichia pastoris as a host for the production of saporin containing chimaeras. FASEB J 2009; in press.
143. Frankel AE, Tagge EP, Willingham MC. Clinical trials of targeted toxins. Semin Cancer Biol 1995; 6: 307-317
144. Sausville EA. Use of immunotoxins in the treatment of lymphoma. Cancer J 2000; 6: 135-138
145. Polito L, Bolognesi A, Tazzari PL, et al. The conjugate Rituximab/saporin-S6 completely inhibits clonogenic growth of CD20-expressing cells and produces a synergistic toxic effect with Fludarabine. Leukemia 2004; 18: 1215-1222 (Pubitemid 39023131)
146. Flavell DJ, Noss A, Pulford KA, Ling N, Flavell SU. Systemic therapy with 3BIT, a triple combination cocktail of anti-CD19, -CD22, and -CD38-saporin immunotoxins, is curative of human Bcell lymphoma in severe combined immunodeficient mice. Cancer Res 1997; 57: 4824-4829 (Pubitemid 27468990)
147. Stirpe F, Battelli MG. Ribosome-inactivating proteins: progress and problems. Cell Mol Life Sci 2006; 63: 1850-1866
148. Baluna R, Coleman E, Jones C, Ghetie V, Vitetta ES. The effect of a monoclonal antibody coupled to ricin A chain-derived peptides on endothelial cells in vitro: insights into toxin-mediated vascular damage. Exp Cell Res 2000; 258: 417-424
149. Lindstrom AL, Pennell CA. In vitro studies of ricin A-chain-induced vascular leak syndrome. Methods Mol Biol 2001; 166: 125-135
150. Smallshaw JE, Ghetie V, Rizo J, et al. Genetic engineering of an immunotoxin to eliminate pulmonary vascular leak in mice. Nat Biotechnol 2003; 21: 387-391 (Pubitemid 36397658)
151. Siegall CB, Liggitt D, Chace D, et al. Characterization of vascular leak syndrome induced by the toxin component of Pseudomonas exotoxin-based immunotoxins and its potential inhibition with non-steroidal anti-inflammatory drugs. Clin Cancer Res 1997; 3: 339-345 (Pubitemid 27158056)
152. Heisler I, Keller J, Tauber R, Sutherland M, Fuchs H. A cleavable adapter to reduce nonspecific cytotoxicity of recombinant immunotoxins. Int J Cancer 2003; 103: 277-282 (Pubitemid 35461522)
153. Thiesen H-J, Juhl H, Arndt R. Selective killing of human bladder cancer cells by combined treatment with A and B chain ricin antibody conjugates. Cancer Res 1987; 47: 419-423 (Pubitemid 17009603)
154. Battelli MG, Polito L, Bolognesi A, Lafleur L, Fradet Y, Stirpe F. Toxicity of ribosome-inactivating proteins containing immunotoxins to a human bladder carcinoma cell line. Int J Cancer 1996; 65: 485-490 (Pubitemid 26084402)
155. Tetzke TA, Caton MC, Maher PA, Parandoosh Z. Effect of fibroblast growth factor saporin mitotoxins on human bladder cell lines. Clin Exp Metastasis 1997; 15: 620-629 (Pubitemid 27435743)
156. Hott JS, Dalakas MC, Sung C, Hallett M, Youle RJ. Skeletal muscle-specific immunotoxin for the treatment of focal muscle spasm. Neurology 1998; 50: 485-491 (Pubitemid 28119794)
157. Hossann M, Li Z, Shi Y, et al. Novel immunotoxin: a fusion protein consisting of gelonin and an acetylcholine receptor fragment as a potential immunotherapeutic agent for the treatment of myasthenia gravis. Protein Expr Purif 2006; 46: 73-84. (Pubitemid 43246998)
158. Harrison AR, Skladzien S, Christiansen SP, McLoon LK. Myotoxic effects of the skeletal muscle-specific immunotoxin, ricin-mAb35, on orbicularis oculi muscle after eyelid injections in rabbits. Ophthalmol Plast Reconstr Surg 2004; 20: 312-316
159. Christiansen SP, Sandnas A, Prill R, Youle RJ, McLoon LK. Acute effects of the skeletal musclespecific immunotoxin ricin-mAb 35 on extraocular muscles of rabbits. Invest. Ophthalmol Vis Sci 2000; 41: 3402-3409
160. Christiansen SP, Peterson D, To T, Youle R, McLoon L. Long-term effects of ricin-mAb 35 on extraocular muscles of rabbits: potential treatment for strabismus. Invest Ophthalmol Vis Sci 2002; 43: 679-685 (Pubitemid 34184484)
161. Campos EC, Schiavi C, Bolognesi A, et al. Selective lesions of rabbit extraocular muscles injected with the anti-AChR immunotoxin saporin-mAb 73. Curr Eye Res 2002; 24: 58-65. (Pubitemid 34765363)
162. Tcherniuk SO, Chroboczek J, Balakirev MY. Construction of tumor-specific toxins using ubiquitin fusion technique. Mol Ther 2005; 11: 196-204.
163. Wiley RG, Kline IV RH. Neuronal lesioning with axonally transported toxins. J Neurosci Methods 2000; 103: 73-82.
164. Wiley RG, Oeltmann TN, Lappi DA. Immunolesioning: Selective destruction of neurons using immunotoxin to rat NGF receptor. Brain Res 1991; 562: 149-153
165. Wiley RG, Lappi DA. Targeted toxins in pain. Advanced Drug Delivery Rev 2003; 55: 1043-1054
166. Wiley RG, Lemons LL, Kline IV RH. Neuropeptide Y Receptor-Expressing dorsal horn neurons: role in nocifensive reflex responses to heat and formalin. Neuroscience 2009; 161: 139-147
167. Smith DC, Gallimore A, Jones E, et al. Exogenous peptides delivered by ricin require processing by signal peptidase for transporter associated with antigen processing-independent MHC class Irestricted presentation. J Immunol 2002; 169: 99-107. (Pubitemid 34686125)
168. st class ticket to class I: protein toxins as pathfinders for antigen presentation. Traffic 2002; 3: 697-704.
169. Smith DC, Marsden CJ, Lord JM, Roberts LM. Expression, Purification and Characterization of Ricin vectors used for exogenous antigen delivery into the MHC Class I presentation pathway. Biol Proced Online 2003; 5: 13-19.
170. + T-cells using a nontoxic recombinant ricin delivery system. Mol Immunol 2007; 44: 993-998
171. Donayre-Torres AJ, Esquivel-Soto E, Gutiérrez-Xicoténcatl Mde L, Esquivel-Guadarrama FR, Gómez-Lim MA. Production and purification of immunologically active core protein p24 from HIV-1 fused to ricin toxin B subunit in E. coli. Virol J 2009; 6: 17-28.
172. Choi NW, Estes MK, Langridge WH. Ricin toxin B subunit enhancement of rotavirus NSP4 immunogenicity in mice. Viral Immunol 2006; 19: 54-63.
173. Choi NW, Estes MK, Langridge WH. Synthesis of a ricin toxin B subunit-rotavirus VP7 fusion protein in potato. Mol Biotechnol 2006; 32: 117-128
174. Johannes L, Decaudin D. Protein toxins: intracellular trafficking for targeted therapy. Gene Ther 2005; 12: 1360-1368 (Pubitemid 43090385)
175. Vingert B, Adotevi O, Patin D, et al. The Shiga toxin B-subunit targets antigen in vivo to dendritic cells and elicits anti-tumor immunity. Eur J Immunol 2006; 36: 1124-1135
176. Adotevi O, Vingert B, Freyburger L, et al. B subunit of Shiga toxin-based vaccines synergize with alpha-galactosylceramide to break tolerance against self antigen and elicit antiviral immunity. J Immunol 2007; 179: 3371-3379
177. Zarovni N, Vago R, Soldà T, Monaco L, Fabbrini MS. Saporin as a novel suicide gene in anticancer gene therapy. Cancer Gene Ther 2007; 14: 165-173 (Pubitemid 46106961)
178. Zarovni N, Vago R, Fabbrini MS. Saporin suicide gene therapy. Methods Mol Biol 2009; 542: 261-283
179. Mehlo L, Gahakwa D, Nghia PT, et al. An alternative strategy for sustainable pest resistance in genetically enhanced crops. Proc Natl Acad Sci USA 2005; 102: 7812-7816 (Pubitemid 40781020)